$PNXP
PINEAPPLE EXPRESS CANNABIS Co

2023 Q2 Form 10-K Financial Statement

#000149315223018877 Filed on May 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2023
Revenue $0.00 $5.385K
YoY Change -100.0% -30.52%
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00 $5.385K
YoY Change -100.0% -30.52%
Gross Profit Margin 100.0%
Selling, General & Admin $29.71K $5.560K $21.70K
YoY Change 189.01% -47.3% -59.69%
% of Gross Profit 402.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $115.00 $0.00 $2.816K
YoY Change -87.77% -100.0% -78.57%
% of Gross Profit 52.29%
Operating Expenses $29.71K $5.560K $21.70K
YoY Change 188.97% -47.3% -59.68%
Operating Profit -$29.71K -$5.560K -$16.32K
YoY Change 427.64% 2.96% -64.59%
Interest Expense $209.3K
YoY Change
% of Operating Profit
Other Income/Expense, Net $209.3K -$28.12K -$28.12K
YoY Change
Pretax Income $179.6K -$33.69K -$44.44K
YoY Change -3289.95% 523.89% -3.55%
Income Tax $0.00
% Of Pretax Income
Net Earnings $179.6K -$33.69K -$44.44K
YoY Change -3289.95% 523.89% -3.55%
Net Earnings / Revenue -825.31%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.01 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 20.34M shares 19.00M shares
Diluted Shares Outstanding 20.30M shares 19.00M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $209.3K
YoY Change 59700.0%
Cash & Equivalents
Short-Term Investments $209.3K
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $2.185K $2.300K
YoY Change -81.79% -82.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.185K $2.300K
YoY Change -81.79% -82.23%
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets $2.185K $2.300K
Total Assets $324.4K $2.300K
YoY Change 2527.09% -87.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.20K $1.306K
YoY Change 7011.11% -71.61%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.20K $546.7K
YoY Change -75.03% 608.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $19.20K $546.7K
Total Long-Term Liabilities $0.00
Total Liabilities $19.20K $546.7K
YoY Change -75.03% 608.92%
SHAREHOLDERS EQUITY
Retained Earnings -$403.4K -$583.0K
YoY Change -825.16%
Common Stock $20.35K $19.01K
YoY Change 408.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $305.2K -$544.4K
YoY Change
Total Liabilities & Shareholders Equity $324.4K $2.300K
YoY Change 2527.09% -87.37%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2023
OPERATING ACTIVITIES
Net Income $179.6K -$33.69K -$44.44K
YoY Change -3289.95% 523.89% -3.55%
Depreciation, Depletion And Amortization $115.00 $0.00 $2.816K
YoY Change -87.77% -100.0% -78.57%
Cash From Operating Activities -$11.70K -$4.440K -$16.73K
YoY Change 29.68% -587.91% -34.79%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $11.70K 4.030K $11.46K
YoY Change 185.29% 706.0% -58.14%
NET CHANGE
Cash From Operating Activities -$11.70K -4.440K -$16.73K
Cash From Investing Activities
Cash From Financing Activities $11.70K 4.030K $11.46K
Net Change In Cash $0.00 -410.0 -$5.269K
YoY Change -100.0% -129.08%
FREE CASH FLOW
Cash From Operating Activities -$11.70K -$4.440K -$16.73K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-223963
CY2023 dei Entity Registrant Name
EntityRegistrantName
PINEAPPLE EXPRESS CANNABIS COMPANY
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4864568
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001710495
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
usd
CY2023Q1 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1 us-gaap Deposits
Deposits
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2022 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
10351 Santa Monica Blvd.
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 420
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90025
CY2023 dei City Area Code
CityAreaCode
888
CY2023 dei Local Phone Number
LocalPhoneNumber
245-5703
CY2023 dei Security12b Title
Security12bTitle
Common stock, par value $0. 001
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20344550 shares
CY2023 dei Auditor Firm
AuditorFirmId
6662
CY2023 dei Auditor Name
AuditorName
M. S. Madhava Rao
CY2023 dei Auditor Location
AuditorLocation
Bangalore, India
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5269 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
5269 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2300 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12940 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
2300 usd
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
12940 usd
CY2023Q1 us-gaap Assets
Assets
2300 usd
CY2022Q1 us-gaap Assets
Assets
18209 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1306 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4599 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45344 usd
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
72515 usd
CY2023Q1 us-gaap Deposits
Deposits
500000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
546650 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
77114 usd
CY2023Q1 us-gaap Liabilities
Liabilities
546650 usd
CY2022Q1 us-gaap Liabilities
Liabilities
77114 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19004550 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19004550 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3734550 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3734550 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
19005 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3735 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19641 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17756 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-582996 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80396 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-544350 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-58905 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2300 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18209 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5385 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7750 usd
CY2023 us-gaap Gross Profit
GrossProfit
5385 usd
CY2022 us-gaap Gross Profit
GrossProfit
7750 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21704 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53883 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
21704 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
53833 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-16319 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-46083 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
-18000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-10124 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28124 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44443 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-44443 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-46083 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19004550 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3734550 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-15913 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3091 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-46083 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-58905 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-58905 usd
CY2023 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-460957 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19955 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-44443 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-44443 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-544350 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-544350 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-44443 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-46083 usd
CY2023 us-gaap Depreciation
Depreciation
2816 usd
CY2022 us-gaap Depreciation
Depreciation
13140 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2696 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3293 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4599 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-18000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
70 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10124 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16726 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25648 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11872 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24280 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3091 usd
CY2023 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
415 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11457 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27371 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5269 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1723 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5269 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3546 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5269 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_z1w5RLzmVX0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zyR30XqfUm0a">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Revenue Recognition Allowances
RevenueRecognitionAllowances
<p id="xdx_841_eus-gaap--RevenueRecognitionAllowances_ziJAlv5x7Deh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zTyPADQpIC6b">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers”. ASC 606 adoption is on February 1, 2018. The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. An entity recognizes revenue in accordance with that core principle by applying the following steps: Step 1: Identify the contract(s) with a customer Step 2: Identify the performance obligations in the contract Step 3: Determine the transaction price Step 4: Allocate the transaction price to the performance obligations in the contract Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. Specifically, Section 606-10-50 requires an entity to provide information about: a. Revenue recognized from contracts with customers, including the disaggregation of revenue into appropriate categories; b. Contract balances, including the opening and closing balances of receivables, contract assets, and contract liabilities; c. Performance obligations, including when the entity typically satisfies its performance obligations and the transaction price that is allocated to the remaining performance obligations in a contract; d. Significant judgments, and changes in judgments, made in applying the requirements to those contracts. For the year ended January 31, 2023, the Company has generated $<span id="xdx_901_eus-gaap--Revenues_c20220201__20230131_zWHVBN5zvMSc">5,385</span> revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Revenues
Revenues
5385 usd
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
40904 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
80396 usd
CY2023Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
16883 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9678 usd
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
16757 usd
CY2021Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7205 usd
CY2022Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
16757 usd
CY2021Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
7205 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-9552 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-4096 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9552 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4096 usd

Files In Submission

Name View Source Status
0001493152-23-018877-index-headers.html Edgar Link pending
0001493152-23-018877-index.html Edgar Link pending
0001493152-23-018877.txt Edgar Link pending
0001493152-23-018877-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mnao-20230131.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mnao-20230131_def.xml Edgar Link unprocessable
mnao-20230131_cal.xml Edgar Link unprocessable
mnao-20230131_lab.xml Edgar Link unprocessable
mnao-20230131_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed